Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. FDA approves Biogen's hemophilia A drug Eloctate
Yahoo/Reuters
Saturday, June 7, 2014 - 8:59am
tags:
Biogen, Eloctate, hemophilia A, hemophilia
Curis Re-Initiates Dosing for CUDC-427
Yahoo/Zacks
Saturday, June 7, 2014 - 8:58am
tags:
Curis, CuDC, solid tumors
Illumina Is How You Play Biotech Without Being in Biotech
The Street
Saturday, June 7, 2014 - 8:55am
tags:
Illumina
Focus On Catalysts To Cash In On Biotech: Jason Kolbert
Seeking Alpha
Saturday, June 7, 2014 - 8:53am
tags:
Shortage Of R&D At Big Pharma Creates Demand For Small Biotech: Joseph Pantginis
Seeking Alpha
Friday, June 6, 2014 - 5:25pm
tags:
R&D, biotech
Questcor's 'Buyout' Could Fall Through
Seeking Alpha
Friday, June 6, 2014 - 5:24pm
tags:
Questcor, Mallinckrodt, Acthar, M&A
FDA approves Biogen's hemophilia A drug Eloctate
Yahoo/Reuters
Friday, June 6, 2014 - 5:22pm
tags:
FDA, Biogen Idec, hemophilia A, Eloctate
[video]Is AstraZeneca Making a Big Mistake With Its Pipeline?
Motley Fool
Friday, June 6, 2014 - 5:17pm
tags:
AstraZeneca
Is Bristol-Myers Squibb's Dividend Safe?
Motley Fool
Friday, June 6, 2014 - 11:55am
tags:
dividends, Bristol-Myers Squibb
Prominent Patient Group Comes out in Support of Distinguishable Names for Biosimilars
Regulatory Focus
Friday, June 6, 2014 - 11:29am
tags:
biosimilars, patients
Ranbaxy decision shows why FDA reluctant to rely on European inspections
Fierce Pharma
Friday, June 6, 2014 - 11:23am
tags:
Ranbaxy, FDA, Europe
Amgen abruptly puts 70 employees on paid leave
InsuranceNewsNet.com
Friday, June 6, 2014 - 10:50am
tags:
Amgen, layoffs
Glaxosmithkline Plc Completes Acquisition Of Human Genome Sciences
Reuters
Friday, June 6, 2014 - 10:09am
tags:
GSK, M&A, Human Genome Sciences
FDA Approves Sanofi SA's and Regeneron Pharmaceuticals Inc's Zaltrap for Metastatic Colorectal Cancer
Reuters
Friday, June 6, 2014 - 10:08am
tags:
FDA, Sanofi, Regneron, Zaltrap, colorectal cancer
GW Pharma receives FDA fast-track designation for Dravet syndrome treatment
Reuters
Friday, June 6, 2014 - 10:07am
tags:
FDA, GW Pharma, fast track, Dravet syndrome, Epidiolex
Should Medtronic Buy Smith & Nephew?
Motley Fool
Friday, June 6, 2014 - 10:06am
tags:
Medtronic, Smith & Nephew, devices, M&A
How Gilead Sciences Can Deliver A Double
Forbes
Friday, June 6, 2014 - 10:05am
tags:
Gilead Sciences, Sovaldi
Bluebird, Agios: Preview of Next Week's Important Pipeline Updates
TheStreet.com
Friday, June 6, 2014 - 9:34am
tags:
Bluebird Bio, Agios, AG-221, Celgene, LentiGlobin
5 Reasons Why We Believe Novogen Is Poised For Success
Seeking Alpha
Thursday, June 5, 2014 - 10:57pm
tags:
Novogen, cancer, stem cells
Positive Data on Vertex Pharma's Kalydeco
Yahoo/Zacks.com
Thursday, June 5, 2014 - 10:56pm
tags:
Kalydeco, Vertex Pharmaceuticals, cystic fibrosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.